Literature DB >> 19488816

Comparison of heparin-coated and conventional split-tip hemodialysis catheters.

Timothy W I Clark1, David Jacobs, Hearns W Charles, Sandor Kovacs, Theresa Aquino, Joseph Erinjeri, Judith A Benstein.   

Abstract

Catheter coatings have the potential to decrease infection and thrombosis in patients with chronic dialysis catheters. We report our midterm experience with a heparin-coated dialysis catheter. This retrospective, case-control study was approved by our Institutional Review Board. A total of 88 tunneled dialysis catheters were inserted over a 13-month period via the internal jugular vein. Thirty-eight uncoated split-tip catheters and 50 heparin-coated catheters were inserted. Primary catheter patency was compared between the two groups using the log rank test, with infection and/or thrombosis considered as catheter failures. Dialysis parameters during the first and last dialysis sessions, including pump speed, actual blood flow, and arterial port pressures, were compared using unpaired t-tests. Primary patency of the uncoated catheters was 86.0 +/- 6.5% at 30 days and 76.1 +/- 8.9% at 90 days. Primary patency of heparin-coated catheters was 92.0 +/- 6.2% at 30 days and 81.6 +/- 8.0% at 90 days (p = 0.87, log rank test). Infection requiring catheter removal occurred in four patients with uncoated catheters and two patients with heparin-coated catheters (p = 0.23). Catheter thrombosis requiring catheter replacement or thrombolysis occurred in one patient with an uncoated catheter and two patients with heparin-coated catheters (p = 0.9). No differences in catheter function during hemodialysis were seen between the two groups. In conclusion, the heparin-coated catheter did not show a significantly longer patency compared to the uncoated catheter. The flow characteristics of this device were comparable to those of the conventional uncoated catheter. A demonstrable benefit of the heparin-coated catheter in randomized trials is needed before a recommendation for routine implementation can be made.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488816      PMCID: PMC9382884          DOI: 10.1007/s00270-009-9608-5

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.797


  12 in total

Review 1.  Reporting standards for central venous access.

Authors:  James E Silberzweig; David Sacks; Azita S Khorsandi; Curtis W Bakal
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

2.  Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults.

Authors:  D A Long; M G Coulthard
Journal:  Anaesth Intensive Care       Date:  2006-08       Impact factor: 1.669

3.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Update: Delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush--Michigan and South Dakota, 2005-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-09-08       Impact factor: 17.586

5.  Fibrin sheath enhances central venous catheter infection.

Authors:  John R Mehall; Daniel A Saltzman; Richard J Jackson; Samuel D Smith
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

6.  Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Authors:  D G Maki; S M Stolz; S Wheeler; L A Mermel
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

7.  Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.

Authors:  Hend Hanna; Robert Benjamin; Ioannis Chatzinikolaou; Badie Alakech; Deborah Richardson; Paul Mansfield; Tanya Dvorak; Mark F Munsell; Rabih Darouiche; Hagop Kantarjian; Issam Raad
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

8.  Vascular access and all-cause mortality: a propensity score analysis.

Authors:  Kevan R Polkinghorne; Stephen P McDonald; Robert C Atkins; Peter G Kerr
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

9.  Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.

Authors:  Abderrahman Abdelkefi; Wafa Achour; Tarek Ben Othman; Saloua Ladeb; Lamia Torjman; Amel Lakhal; Assia Ben Hassen; Mohamed Hsairi; Abdeladhim Ben Abdeladhim
Journal:  J Support Oncol       Date:  2007-06

10.  The relationship between the thrombotic and infectious complications of central venous catheters.

Authors:  I I Raad; M Luna; S A Khalil; J W Costerton; C Lam; G P Bodey
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

View more
  6 in total

1.  The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.

Authors:  Terry C Major; Elizabeth J Brisbois; Anna M Jones; Margaux E Zanetti; Gail M Annich; Robert H Bartlett; Hitesh Handa
Journal:  Biomaterials       Date:  2014-06-10       Impact factor: 12.479

Review 2.  Update on Insertion and Complications of Central Venous Catheters for Hemodialysis.

Authors:  Peter R Bream
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  Does the heparin lock concentration affect hemodialysis catheter patency?

Authors:  D Maya Ivan; Tamorie Smith; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

4.  Minimizing hemodialysis catheter dysfunction: an ounce of prevention.

Authors:  Timmy Lee; Charmaine Lok; Miguel Vazquez; Louise Moist; Ivan Maya; Michele Mokrzycki
Journal:  Int J Nephrol       Date:  2012-02-19

Review 5.  Central Venous Catheters for Hemodialysis-the Myth and the Evidence.

Authors:  Mohammad Ahsan Sohail; Tushar J Vachharajani; Evamaria Anvari
Journal:  Kidney Int Rep       Date:  2021-10-11

6.  How to deal with dialysis catheters in the ICU setting.

Authors:  Natacha Mrozek; Alexandre Lautrette; Jean-François Timsit; Bertrand Souweine
Journal:  Ann Intensive Care       Date:  2012-11-23       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.